+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Mapping Devices Market Size, Share & Trends Analysis Report, By Type (Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems), By Indication (Atrial Fibrillation, Atrial Flutter), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5990715
Description Jump to:
The global cardiac mapping devices market size is expected to reach USD 3.69 billion by 2030, registering a CAGR of 9.1% from 2024 to 2030, according to a new report. The primary factors driving the market expansion include the rising arrhythmia cases & number of cardiac surgery patients, growing geriatric population, technological advancements in cardiac mapping systems, and supportive government initiatives. According to the Heart Rhythm Society article published in August 2023, Atrial fibrillation (AFib), the most common type of cardiac arrhythmia, affects nearly 40 million people worldwide, including 6 million in the U.S. Its widespread prevalence underscores the need for advanced diagnostic and treatment options.

Approximately 1 in 4 adults over 40 are at risk of developing AFib, yet many are unaware of its symptoms, available treatments, and the importance of early intervention to prevent progression. Advancements in cardiac mapping systems also drive market growth. For instance, in June 2024, new mapping techniques, such as multielectrode baskets and catheters mapping across cardiac arteries and veins on the epicardium, enabled three-dimensional activation sequence definition during vacuum therapy. Computerized non-contact mapping uses mathematical algorithms to reconstruct electrograms and generate three-dimensional isopotential maps without direct heart endocardium contact.

Advances in remote monitoring and infection prevention in cardiac electrophysiology support continuous patient heart rhythm monitoring outside clinical settings, allowing prompt treatment adjustments and reducing invasive procedure infection risks. Moreover, several strategic initiatives by key players fuel the market's growth. For instance, in July 2024, Johnson & Johnson's Biosense Webster launched the Optrell mapping catheter, incorporating TrueRef technology. Designed in Irvine, California, by Biosense Webster, Optrell is a high-density diagnostic catheter that integrates with the Carto 3 system. It utilizes small electrodes in a fixed array configuration to provide accurate electrophysiological mapping for complex cardiac arrhythmias.

Cardiac Mapping Devices Market Report Highlights

  • The contact cardiac mapping systems segment held the largest share of over 57.07%, in 2023 due to technological advancements, strategic initiatives by key players, and a rising volume of cardiac procedures
  • The atrial fibrillation segment held the largest share of over 45.87% in 2023 due to increased cases of arrhythmia and high geriatric population
  • The hospitals segment held the largest share of 69.38% in 2023. Hospitals play a vital role in adopting and assessing new technologies, such as advanced cardiac mapping devices. These devices enable hospitals to deliver state-of-the-art care for patients with cardiac arrhythmias, ensuring better outcomes and advancing the field of electrophysiology
  • North America dominated the global market with a share of 41.39% in 2023 owing to the increased cases of cardiovascular diseases (CVDs), including arrhythmias. Product launches, regulatory approvals, and advanced healthcare infrastructure


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Indication
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecast timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Segment
2.2.2. Indication Segment
2.2.3. End-use Segment
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Global Cardiac Mapping Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing number of cardiac surgery patients
3.2.1.2. Rising arrhythmia cases
3.2.1.3. Technological advancements in mapping systems
3.2.1.4. Growing number of cardiovascular diseases (CVD)
3.2.1.5. Rising geriatric population
3.2.2. Market restraint analysis
3.2.2.1. High cost of cardiac mapping systems
3.2.2.2. Lack of adequate infrastructure
3.3. Cardiac Mapping Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Cardiac Mapping Devices Market: Type Estimates & Trend Analysis
4.1. Cardiac Mapping Devices Market: Type Dashboard
4.2. Cardiac Mapping Devices Market: Type Movement Analysis
4.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Contact cardiac mapping systems
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Non-contact cardiac mapping systems
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Cardiac Mapping Devices Market: Indication Estimates & Trend Analysis
5.1. Cardiac Mapping Devices Market: Indication Dashboard
5.2. Cardiac Mapping Devices Market: Indication Movement Analysis
5.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
5.4. Atrial Fibrillation
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Atrial Flutter
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Cardiac Mapping Devices Market: End Use Estimates & Trend Analysis
6.1. Cardiac Mapping Devices Market: End Use Dashboard
6.2. Cardiac Mapping Devices Market: End Use Movement Analysis
6.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Diagnostic Centers
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Cardiac Mapping Devices Market: Regional Estimates & Trend Analysis by Country, Type, End-use, & End Use
7.1. Global Cardiac Mapping Devices Market: Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamics
7.3.4.2. Regulatory framework/ reimbursement structure
7.3.4.3. Competitive scenario
7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
7.4.8. Norway
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
7.4.9. Denmark
7.4.9.1. Key country dynamics
7.4.9.2. Regulatory framework/reimbursement structure
7.4.9.3. Competitive scenario
7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3. Japan
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4. India
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
7.5.7. South Korea
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework/ reimbursement structure
7.5.7.3. Competitive scenario
7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
7.7.3. South Africa
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Manufacturers
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Abbott
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Medtronic
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. BIOTRONIK
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Acutus Medical
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. APN Health, LLC
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Johnson & Johnson
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biosig Technologies, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Boston Scientific Corporation
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Kardium, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Koninklijke Philips N.V
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Microport Scientific Corporation
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Global cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 4 Global cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 5 Global cardiac mapping devices market, by end-use, 2018 - 2030
Table 6 Global cardiac mapping devices market, by region, 2018 - 2030 (USD Million)
Table 7 North America cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
Table 8 North America cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 9 North America cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 10 North America cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 11 U.S. cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 12 U.S. cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 13 U.S. cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 14 Canada cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 15 Canada cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 16 Canada cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 17 Mexico cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 18 Mexico cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 19 Mexico cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 20 Europe cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
Table 21 Europe cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 22 Europe cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 23 Europe cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 24 UK cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 25 UK cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 26 UK cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 27 Germany cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 28 Germany cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 29 Germany cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 30 France cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 31 France cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 32 France cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 33 Italy cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 34 Italy cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 35 Italy cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 36 Spain cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 37 Spain cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 38 Spain cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 39 Denmark cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 40 Denmark cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 41 Denmark cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 42 Sweden cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 43 Sweden cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 44 Sweden cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 45 Norway cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 46 Norway cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 47 Norway cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 48 Asia Pacific cardiac mapping devices market, by Country, 2018 - 2030 (USD Million)
Table 49 Asia Pacific cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 51 Asia Pacific cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 52 Japan cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 53 Japan cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 54 Japan cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 55 China cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 56 China cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 57 China cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 58 India cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 59 India cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 60 India cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 61 Australia cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
Table 62 Australia cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 63 Australia cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 64 Australia cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 65 Thailand cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 67 Thailand cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 68 Thailand cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 69 South Korea cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 70 South Korea cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 71 South Korea cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 72 Latin America cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
Table 73 Latin America cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 74 Latin America cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 75 Latin America cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 76 Brazil cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 77 Brazil cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 78 Brazil cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 79 Argentina cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 80 Argentina cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 81 Argentina cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 82 MEA cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
Table 83 MEA cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 84 MEA cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 85 MEA cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 86 South Africa cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 87 South Africa cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 88 South Africa cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 91 Saudi Arabia cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 92 UAE cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 93 UAE cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 94 UAE cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 95 Kuwait cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
Table 96 Kuwait cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
Table 97 Kuwait cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
Table 98 Participant’s overview
Table 99 Financial performance
Table 100 Key companies undergoing expansions
Table 101 Key companies undergoing acquisitions
Table 102 Key companies undergoing collaborations
Table 103 Key companies launching new types/services
Table 104 Key companies undergoing partnerships
Table 105 Key companies undertaking other strategies
List of Figures
Fig. 1 Cardiac mapping devices market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Cardiac mapping devices market revenues, 2023, (USD Millions)
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Porter’s five forces analysis
Fig. 12 PESTLE analysis
Fig. 13 Cardiac mapping devices market type outlook:
Fig. 14 Cardiac mapping devices market: type movement analysis
Fig. 15 Segment dashboard
Fig. 16 Global contact cardiac mapping systems market, 2018 - 2030 (USD Million)
Fig. 17 Global non-contact cardiac mapping systems market, 2018 - 2030 (USD Million)
Fig. 18 Cardiac mapping devices market indication outlook:
Fig. 19 Cardiac mapping devices market: indication movement analysis
Fig. 20 Global atrial fibrillation market, 2018 - 2030 (USD Million)
Fig. 21 Global atrial flutter market, 2018 - 2030 (USD Million)
Fig. 22 Global others market, 2018 - 2030 (USD Million)
Fig. 23 Cardiac mapping devices market end-use outlook:
Fig. 24 Cardiac mapping devices market: end-use movement analysis
Fig. 25 Global hospitals market, 2018 - 2030 (USD Million)
Fig. 26 Global diagnostic centers market, 2018 - 2030 (USD Million)
Fig. 27 Global others market, 2018 - 2030 (USD Million)
Fig. 28 Regional market place: Key takeaways
Fig. 29 North America cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 30 U.S. cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 31 Canada cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 32 Mexico cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 33 Europe cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 34 Germany cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 35 UK cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 36 France cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 37 Italy cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 38 Spain cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 39 Asia Pacific cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 40 Japan cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 41 China cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 42 India cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 43 Australia cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 44 Latin America cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 45 Brazil cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 46 MEA cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 47 South Africa cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 48 Saudi Arabia cardiac mapping devices market, 2018 - 2030 (USD Million)
Fig. 49 Market Participant Categorization
Fig. 50 Strategy mapping

Companies Mentioned

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • BIOTRONIK
  • MicroPort Scientific Corporation
  • APN HEALTH
  • Acutus Medical, Inc.
  • Kardium
  • BioSig Technologies, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.02 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.69 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Implantable Cardiac Rhythm Management Device Market Size, Share & Trends Analysis Report By Product (Pacemaker, ICDs, CRT), By End-use (Hospitals, Specialty Cardiac Centers), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Implantable Cardiac Rhythm Management Device Market Size, Share & Trends Analysis Report By Product (Pacemaker, ICDs, CRT), By End-use (Hospitals, Specialty Cardiac Centers), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report by Products (Pacemakers (Implantable, External), Defibrillators, Cardiac Resynchronization Therapy), Region, and Segment Forecasts, 2025-2030 - Product Image

Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report by Products (Pacemakers (Implantable, External), Defibrillators, Cardiac Resynchronization Therapy), Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Cardiac Mapping Market by Type, Indication, Technology, End-User - Global Forecast 2025-2030 - Product Image

Cardiac Mapping Market by Type, Indication, Technology, End-User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Cardiac Ablation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Cardiac Ablation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Cardiac Mapping Market Analysis & Forecast to 2024-2034 - Product Image

Cardiac Mapping Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.